![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1320951 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of SNRPB2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1320951 | 6480464 | Ethinyl Estradiol results in increased expression of SNRPB2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | RGD:1320951 | 6480464 | Estradiol results in increased expression of SNRPB2 mRNA | CTD | PMID:30077407 | 17beta-estradiol | multiple interactions | ISO | RGD:1320951 | 6480464 | [Polyphenols co-treated with Estradiol] results in decreased expression of SNRPB2 mRNA | CTD | PMID:30077407 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:1320951 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:1320950 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320951 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNRPB2 mRNA | CTD | PMID:16962184 | 2,4,6-tribromophenol | decreases expression | ISO | RGD:1320950 | 6480464 | 2 more ... | CTD | PMID:31675489 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:1320950 | 6480464 | tetrabromobisphenol A results in decreased expression of SNRPB2 protein | CTD | PMID:31675489 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1320950 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPB2 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SNRPB2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | RGD:1320950 | 6480464 | Aflatoxin B1 results in decreased methylation of SNRPB2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | RGD:1320950 | 6480464 | Tretinoin results in increased expression of SNRPB2 mRNA | CTD | PMID:33167477 | arsenite(3-) | multiple interactions | ISO | RGD:1320950 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to SNRPB2 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | RGD:1320951 | 6480464 | Benzo(a)pyrene results in increased expression of SNRPB2 mRNA | CTD | PMID:20504355 | benzo[a]pyrene | increases expression | ISO | RGD:1320950 | 6480464 | Benzo(a)pyrene results in increased expression of SNRPB2 protein | CTD | PMID:33278487 | benzo[a]pyrene | increases methylation | ISO | RGD:1320950 | 6480464 | Benzo(a)pyrene results in increased methylation of SNRPB2 5' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNRPB2 mRNA | CTD | PMID:30816183 more ... | bisphenol A | decreases expression | ISO | RGD:1320950 | 6480464 | bisphenol A results in decreased expression of SNRPB2 protein | CTD | PMID:31675489 | bisphenol F | multiple interactions | ISO | RGD:1320950 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPB2 mRNA | CTD | PMID:28628672 | cadmium atom | multiple interactions | ISO | RGD:1320950 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNRPB2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1320950 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNRPB2 mRNA | CTD | PMID:35301059 | carmustine | increases expression | ISO | RGD:1320950 | 6480464 | Carmustine results in increased expression of SNRPB2 mRNA | CTD | PMID:15980968 | CGP 52608 | multiple interactions | ISO | RGD:1320950 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SNRPB2 gene] | CTD | PMID:28238834 | copper atom | multiple interactions | ISO | RGD:1320950 | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of SNRPB2 mRNA | CTD | PMID:24690739 | copper(0) | multiple interactions | ISO | RGD:1320950 | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of SNRPB2 mRNA | CTD | PMID:24690739 | decabromodiphenyl ether | decreases expression | ISO | RGD:1320950 | 6480464 | decabromobiphenyl ether results in decreased expression of SNRPB2 protein | CTD | PMID:31675489 | dexamethasone | multiple interactions | ISO | RGD:1320950 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPB2 mRNA | CTD | PMID:28628672 | disulfiram | multiple interactions | ISO | RGD:1320950 | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of SNRPB2 mRNA | CTD | PMID:24690739 | ethanol | increases expression | ISO | RGD:1320951 | 6480464 | Ethanol results in increased expression of SNRPB2 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of SNRPB2 mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of SNRPB2 mRNA | CTD | PMID:24136188 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of SNRPB2 mRNA | CTD | PMID:17341692 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SNRPB2 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SNRPB2 mRNA | CTD | PMID:33387578 | gold atom | decreases expression | ISO | RGD:1320950 | 6480464 | Gold results in decreased expression of SNRPB2 mRNA | CTD | PMID:25523186 | gold(0) | decreases expression | ISO | RGD:1320950 | 6480464 | Gold results in decreased expression of SNRPB2 mRNA | CTD | PMID:25523186 | hydralazine | multiple interactions | ISO | RGD:1320950 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB2 mRNA | CTD | PMID:17183730 | indometacin | multiple interactions | ISO | RGD:1320950 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPB2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:1320950 | 6480464 | Ivermectin results in decreased expression of SNRPB2 protein | CTD | PMID:32959892 | methylmercury chloride | decreases expression | ISO | RGD:1320950 | 6480464 | methylmercuric chloride results in decreased expression of SNRPB2 mRNA | CTD | PMID:28001369 | nickel sulfate | decreases expression | ISO | RGD:1320950 | 6480464 | nickel sulfate results in decreased expression of SNRPB2 mRNA | CTD | PMID:22714537 | perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:1320951 | 6480464 | perfluorooctane sulfonic acid affects the expression of SNRPB2 mRNA | CTD | PMID:19429403 | perfluorooctanoic acid | affects expression | ISO | RGD:1320951 | 6480464 | perfluorooctanoic acid affects the expression of SNRPB2 mRNA | CTD | PMID:19429403 | pinosylvin | decreases expression | ISO | RGD:1320950 | 6480464 | pinosylvin results in decreased expression of SNRPB2 mRNA | CTD | PMID:23333577 | resveratrol | decreases expression | ISO | RGD:1320951 | 6480464 | resveratrol results in decreased expression of SNRPB2 protein | CTD | PMID:25505154 | sodium arsenite | decreases expression | ISO | RGD:1320950 | 6480464 | sodium arsenite results in decreased expression of SNRPB2 mRNA | CTD | PMID:22714537 | temozolomide | increases expression | ISO | RGD:1320950 | 6480464 | Temozolomide results in increased expression of SNRPB2 mRNA | CTD | PMID:31758290 | tolcapone | decreases expression | EXP | | 6480464 | tolcapone results in decreased expression of SNRPB2 mRNA | CTD | PMID:24136188 | trans-pinosylvin | decreases expression | ISO | RGD:1320950 | 6480464 | pinosylvin results in decreased expression of SNRPB2 mRNA | CTD | PMID:23333577 | tungsten | increases expression | ISO | RGD:1320951 | 6480464 | Tungsten results in increased expression of SNRPB2 mRNA | CTD | PMID:30912803 | valproic acid | multiple interactions | ISO | RGD:1320950 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB2 mRNA | CTD | PMID:17183730 | valproic acid | affects expression | ISO | RGD:1320951 | 6480464 | Valproic Acid affects the expression of SNRPB2 mRNA | CTD | PMID:17963808 | |